Apollo Health Ventures

As seed investors early on, we are thrilled that our portfolio company HAYA Therapeutics has received the prestigious Andreas & Thomas Strüngmann Award, celebrating their advancements in developing targeted treatments for chronic diseases. This recognition highlights the groundbreaking advancements that HAYA is making in RNA technology, which aligns with Apollo Health Ventures’ mission to support companies at the forefront of scientific innovation. We are proud to be part of HAYA’s journey and look forward to witnessing their continued success in transforming healthcare. The award was established in honor of Andreas Strüngmann, M.D., and Thomas Strüngmann, Ph.D., who have significantly impacted the life sciences through their entrepreneurial achievements and visionary investments – such as their early investment in BioNTech. For a more in-depth look at HAYA’s innovative work and their recognition, check out the full story in Handelsblatt: https://lnkd.in/eJW4G9zn #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Apollo Health Ventures has been spotlighted by Michael Greve from Kizoo Ventures as one of the top five VCs to watch in the longevity and biotech space in a recent article in Gründerszene by Nina Anika Klotz: https://lnkd.in/ezQvtiEg A Science Magazine article explores how recent research highlights the potential of enhanced communication between organs to slow aging. By improving neural signals, this novel approach promises to extend healthspan and delay age-related deterioration: https://lnkd.in/eqNBw5Yi “How to invest in biotech” – The Financial Times reports on the resurgence of biotech investments, highlighting innovative treatments from dementia to diabetes. Read why the sector’s potential is immense: https://lnkd.in/efxPBiuP A new study in GeroScience by Springer Nature Group sheds light on the remarkable longevity of naked mole-rats, whose aging process defies conventional wisdom. This offers promising insights into how we might extend human health spans: https://lnkd.in/d3EBGaME #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital

Excited to share my recent appearance on the 'Making Sense of Science' podcast with Matt Fuchs by Upworthy Science! We discussed Apollo Health Ventures' pioneering work in developing therapeutics to enhance and extend healthy lifespans. During the episode, we explored the present and future of therapeutics aimed at increasing #healthspan, the benefits of certain lifestyle practices, and the best use of electronic wearables. I also shared insights on #rapamycin, including my personal views on whether to take it for longevity. If you're passionate about the future of biotech and medicine for healthy longevity, let's connect and explore potential collaborations! Tune in to the full conversation on Upworthy Science: https://lnkd.in/debryPjN #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital 🌟💡

We are honored to have been featured in the German newspaper Der Tagesspiegel’s coverage of the growing longevity movement, focusing on Berlin, as it hosted its first „Longevity-Week“. Jan Adams, our Venture Partner, shares insights on Berlin’s potential to lead Europe in longevity, emphasizing our strategic contributions to this sector. Let us know in the comments if you want us to send you a translation of the article, or read the full article here: https://lnkd.in/eUvz_a5U #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Our portfolio company HAYA Therapeutics has been nominated as a finalist in the newly launched Andreas & Thomas Strüngmann Award which honors outstanding entrepreneurial talent and accomplishments in the field of life sciences: https://lnkd.in/dBvvTNKJ A recent study published in Nature Portfolio has shown the potential of rejuvenating the immune system to slow aging. Studies in mice show that revitalizing the immune system can invigorate multiple body organs, offering new ways to tackle age-related diseases: https://lnkd.in/dX-UnDFM Researchers at Penn State University have discovered new insights into the link between caloric restriction and aging. The study examined how reducing calorie intake affects telomere length, a key biomarker of aging: https://lnkd.in/eMEmSuug #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital

If you are in Porto today, come and see our Venture Partner, Christopher R. Shepard, as he holds a talk titled "Immune System Reconstitution by Regeneration of Thymus Function with Small Molecule Medicines." Presenting to researchers and students to share Thymus and T-cell biology advancements, the talk will focus on his work with our creation lab venture, ThymoFox (www.thymofox.com). Drop Christopher R. Shepard a message if you are in town and want to meet up. #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Meet us in San Diego at the BIO International Convention from June 3rd – 7th. Our Partner Jan Adams will explore new opportunities and collaborations at this biotech event, which hosts over 20,000 industry leaders globally and represents the full biotechnology ecosystem. Reach out if you are in town or let us know via email: info@apollo.vc #BIO2024 #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Longevity investment hits $3.01 B according to Longevity.Technology’s 2023 annual investment report. This highlights the growing interest and resilience in the longevity industry, despite overall market challenges – with significant advancements expected in the future: https://lnkd.in/dsMeKQhN In a recent The Times article, Eric Schmidt, former CEO & Chairman of Google, discusses the transformative potential of biotechnology, emphasizing the critical intersection of AI and biotech, and the opportunity for biotech’s “ChatGPT moment,”: https://lnkd.in/g2EKGfC5 A study in Nature Portfolio Aging shows that reintroducing reprogramming transcription factors in aged mice enhances neuroblast production, restoring younger cellular profiles and improving brain function: https://lnkd.in/enMUYzsd Another study found that small extracellular vesicles from young mice can reverse aging-related declines in older mice by boosting mitochondrial energy metabolism, extending lifespan, improving physiological functions, and stimulating PGC-1α expression crucial for energy production: https://lnkd.in/eCkz4zxb  #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital

Meet our Venture Partner, Christopher R. Shepard at the ThymE 24 from May 27th – 31st in Porto. Organized by i3S - Instituto de Investigação e Inovação em Saúde, this European conference brings together researchers and students to share Thymus and T-cell biology advancements, covering topics from organogenesis to immunotherapies and aging. Reach out if you are in town or let us know via email: info@apollo.vc #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Our portfolio company, Ochre Bio, is working towards transforming the treatment of liver diseases. Jack O'Meara, the Co-Founder and CEO of Ochre Bio, spoke with Judy Khan Shaw on NYSE's Floor Talk to discuss their unique 'human first' approach and how their use of machine learning technology sets them apart in the field of drug development. Watch the full interview here: https://lnkd.in/emGsks7K Scientific American, in partnership with the Davos Alzheimer's Collaborative, has released a special report called ‘The New Age of Alzheimer's’ with contributions by Bill Gates, Elias Zerhouni, and Hilary Evans. The report explores the latest advances in the field that could potentially delay or even prevent dementia and new approaches to support brain health in the world's aging population: https://lnkd.in/eUfd4RQD A recent study highlights how long-lived individuals (LLIs) in China exhibit lower epigenetic noise, particularly in gene promoters, contributing to healthier aging. This discovery could enhance our understanding of longevity and age-related diseases: https://lnkd.in/eD7N7tth A recent review examines the physiological and pathological roles of the senescence-associated secretory phenotype (SASP). This research highlights how SASP influences aging and various diseases, shedding light on potential therapeutic targets for treating age-related conditions: https://lnkd.in/evHmv-BM #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital